Home › Biotech Deserves A Piece Of Every Dividend Growth Portfolio
 

Keywords :   


Biotech Deserves A Piece Of Every Dividend Growth Portfolio

2016-01-26 07:14:29| Biotech - Topix.net

Taking into account their projected EPS growth rates and potential for dividend growth, both companies, but in particular Gilead Sciences, are attractively valued relative to the market. Amgen became a pioneer in the biotech world when it became the first large biotech stock to begin paying a regular dividend in 2011.

Tags: growth piece portfolio biotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 7
05.11Tropical Storm Rafael Public Advisory Number 7
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 7
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
More »